Read Jamie Madrigal, Dougald Monroe, Suzanne Sindi and Karin Leiderman’s Latest Analysis on Emicizumab
Journal of Thrombosis and Haemostasis (JTH) shared on LinkedIn:
”Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
This study used mathematical modeling and biochemical assays to dissect how emicizumab, a bispecific antibody bridging activated factor IXa and factor X, functions differently from factor VIII.
It revealed that high emicizumab levels inhibit factor X activation via tissue factor pathway due to reduced lipid surface binding but enhance factor IXa-dependent activation of factor X on lipid surfaces.
The model provides kinetic estimates and explains emicizumab’s mechanism of enhancing coagulation through lipid-surface interactions.
Read this paper.
Authors: Jamie Madrigal, Dougald Monroe, Suzanne Sindi, Karin Leiderman”
Read the full article in JTH.
Article: Mathematical analysis of emicizumab: affinity-driven complex formation and lipid-surface reactions
Authors: Jamie Madrigal, Dougald Monroe, Suzanne Sindi, Karin Leiderman

Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 13:56Suzan Osman: The Major Types of Intracranial Hemorrhage in Clinical Practice
-
May 27, 2026, 13:55Raimundo C. Santos: The Main Aggressors of the Aorta and What These Lead to
-
May 27, 2026, 13:54Pooja Choradia: 2026 Acute Pulmonary Embolism Clinical Guidelines
-
May 27, 2026, 13:53Rehab Hussein: Blood Bank Training and the Clinical Responsibility of Preserving Human Life
-
May 27, 2026, 13:42New EAS Consensus Highlights Advances in Pediatric FH Care
-
May 27, 2026, 13:10Amos Gitonga Mbaabu: Global Partnerships Supporting Hemophilia and Sickle Cell Care in Africa
-
May 27, 2026, 09:58Omid Seidizadeh: Take The EAHAD Survey on Access to Diagnosis and Treatment for VWD Europe
-
May 27, 2026, 09:51Richard Benjamin: RedeS Phase III Trial Reaches Major Milestone in Advancing Pathogen-Reduced RBCs for Transfusion
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome